Abstract:The risk of developing Alzheimer’s disease (AD) significantly increases in individuals carrying the allele. Elderly cognitively healthy individuals with also exist, suggesting the presence of cellular mechanisms that counteract the pathological effects of ; however, these mechanisms are unknown. We hypothesized that carriers without dementia might carry genetic variations that could protect them from developing mediated AD pathology. To test this, we leveraged whole genome sequencing (WGS) data in National Institute on Aging Alzheimer’s Disease Family Based Study (NIA-AD FBS), Washington Heights/Inwood Columbia Aging Project (WHICAP), and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) cohorts and identified potentially protective variants segregating exclusively among unaffected carriers. In homozygous unaffected carriers above 70 years old, we identified 510 rare coding variants. Pathway analysis of the genes harboring these variants showed significant enrichment in extracellular matrix (ECM)-related processes, suggesting protective effects of functional modifications in ECM proteins. We prioritized two genes that were highly represented in the ECM-related gene ontology terms, and collagen type VI alpha 2 chain ( ) and are known to be expressed at the blood-brain barrier (BBB), for postmortem validation and functional studies. The FN1 and COL6A2 protein levels were increased at the BBB in carriers with AD. Brain expression of cognitively unaffected homozygous carriers had significantly lower FN1 deposition and less reactive gliosis compared to homozygous carriers with AD, suggesting that FN1 might be a downstream driver of -mediated AD-related pathology and cognitive decline. To validate our findings, we used zebrafish models with loss-of-function (LOF) mutations in – the ortholog for human . We found that fibronectin LOF reduced gliosis, enhanced gliovascular remodeling and potentiated the microglial response, suggesting that pathological accumulation of FN1 could impair toxic protein clearance, which is ameliorated with LOF. Our study suggests vascular deposition of FN1 is related to the pathogenicity of , LOF variants in FN1 may reduce -related AD risk, providing novel clues to potential therapeutic interventions targeting the ECM to mitigate AD risk.

A novel variant in FN1 in a family with fibronectin glomerulopathy

Fibronectin glomerulopathy in an elderly patient with FN1 gene mutation: a case report and literature review

A case of unexpected diagnosis of fibronectin glomerulopathy with histological features of membranoproliferative glomerulonephritis

Bilateral Periventricular Nodular Heterotopia Caused By A Novel Splicing Mutation In The Flna Gene In A Chinese Family

Case Report and Literature Review: A De Novo Pathogenic Missense Variant in ACTN4 Gene Caused Rapid Progression to End-Stage Renal Disease

Fibronectin Glomerulopathy:Clinical and Morphological Features

Fabry Disease with Genetic Variants of Unknown Significance and Concomitant Immunoglobulin A Nephropathy

Aberrant serum-derived FN1 variants bind to integrin β1 on glomerular endothelial cells contributing to thin basement membrane nephropathy

Previously Unidentified Gene Variation Associated with Fabry Disease: The Impact on One Family

Case Report: A Synonymous Mutation in <i>NF1</i> Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping

Identification of a novel mutation in FBN1 in a Chinese family with inherited ectopia lentis by targeted NGS

A Novel Missense Mutation in the FERM Domain Containing 7 (FRMD7) Gene Causing X-linked Idiopathic Congenital Nystagmus in a Chinese Family.

Clinical and Morphological Features of Fibronectin Glomerulopathy: a Report of Ten Patients from a Single Institution

Fibronectin glomerulopathy in a kidney allograft biopsy

A novel FBN1 missense mutation (p.C102Y) associated with ectopia lentis syndrome in a Chinese family.

FGD1 Variant Associated with Aarskog–Scott Syndrome

A Novel LMX1B Variant Identified in a Patient Presenting with Severe Renal Involvement and Thin Glomerular Basement Membrane

Rare genetic variation in Fibronectin 1 ( ) protects against in Alzheimer’s disease

Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family

Updates on the Diagnosis and Management of Fibrillary Glomerulonephritis

Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient